Skip to content
AusGrant
National Closing soon UK-UKRI-UK-UKRI-379DBD9509065E265544FCDBAB1A2005

Expression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D

UK Research and Innovation (UKRI) · Competitive · Research & Development

At a glance

Expression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D is a national competitive grant from UK Research and Innovation for the research & development sector. Funding is up to £4M. Eligible applicants: See the official UKRI opportunity page; eligibility varies by council and call - most require UK-based researchers or organisations. The application deadline is October 20, 2026. Apply via the official listing at www.ukri.org.

Amount
Up to £4M
Deadline
20 Oct 2026
Type
Competitive
Status
Closing soon

About this program

Funding opportunity Funding opportunity: Expression of interest: Chemical, biological, radiological and nuclear (CBRN) medical countermeasures R&D Opportunity status: Open Funders: Medical Research Council (MRC) Co-funders: Department of Health and Social Care (DHSC) Funding type: Grant Total fund: £20,000,000 Publication date: 10 September 2026 Opening date: 10 September 2026 9:00am UK time Closing date: 20 October 2026 4:00pm UK time Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions across any stage of the developmental pathway, from prototype development, through pre-clinical refinement, to early-phase clinical studies (up to phase 2a) for CBRN threats. Applications must demonstrate how the proposed research will result in improved domestic preparedness for CBRN threats. There is a funding limit of £4 million per application...

Who can apply

See the official UKRI opportunity page; eligibility varies by council and call - most require UK-based researchers or organisations.

How to apply

Apply through the UKRI Funding Service as directed on the official opportunity page linked below.

Apply at official source